Elevated sclerostin levels contribute to reduced bone mineral density in non-ambulatory stroke patients
Osteoporosis following stroke is a significant impediment to patient recovery. Decreased mechanical loading and locomotion following the onset of paralysis in stroke patients, especially those who are non-ambulatory, contributes greatly to bone loss. Sclerostin, a protein encoded by the SOST gene, a...
Saved in:
| Main Authors: | Hye Kyoung Lee, Geneva Rose Notario, Sun Young Won, Jung Hwan Kim, Su Min Lee, Ha Seong Kim, Sung-Rae Cho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Bone Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187225000063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum sclerostin in vascular calcification in CKD: a meta-analysis
by: Yan Lin, et al.
Published: (2023-12-01) -
Sclerostin and Cardiovascular Risk: Evaluating the Cardiovascular Safety of Romosozumab in Osteoporosis Treatment
by: Shi-Hsun Chiu, et al.
Published: (2024-12-01) -
Progress of studies on sclerostin’s role in vascular calcification of chronic kidney disease
by: PENG Qiong-yao, et al.
Published: (2019-01-01) -
Association of total and bioactive serum sclerostin levels with bone metabolism in type 2 diabetes mellitus
by: Cyril Traechslin, et al.
Published: (2025-06-01) -
Sclerostin levels in patients with acromegaly
by: Arnika Wydra, et al.
Published: (2025-08-01)